Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

Keo McKenzie re-joins firm’s Washington, DC office, bringing over a decade of experience in AI, healthcare, and technology law. Already registered?

3 October 2024 Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of ...

For more information on individual annual subscriptions for full paid access and corporate subscription options please ...

Association’s annual event is held in China for the first time I Vice premier of China, Zhang Guoqing, delivers Xi's message ...

Columbia court backs FDA approval of Entresto generic I Novartis appealing August ruling in Delaware that denied injunction. If you don't have a login or your access has expired, you will need to ...

13 May 2024 As Congress considers the Patent Eligibility Restoration Act of 2023, experts from NeoGenomics, Biogen, and ...

4 July 2024 UK leg of global litigation over mRNA tech sees patents ruled valid and invalid | Justice Meade follows EPO in ...

As  the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

On September 5, 2022, the China National Intellectual Property Association (China’s patent administrative office, hereinafter ...